文献速递头颈技术与安全USCTPET

甲状旁腺脂肪腺瘤的多模态影像与临床病理特征

Multimodal Imaging and Clinicopathologic Features of Parathyroid Lipoadenoma.
PubMed 文献 · AJNR Am J Neuroradiol · 2026-02-03

本文回顾性分析4例经病理证实且伴原发性甲状旁腺功能亢进生化证据的甲状旁腺脂肪腺瘤患者,所有患者PTH升高、血钙处于正常高值至升高水平。超声呈高回声,CT呈脂肪等效衰减,sestamibi SPECT/CT呈摄取增高,手术切除后术中PTH明显下降并获术后生化治愈,病理均证实间质脂肪>50%。

要点

  • 超声高回声、CT脂肪等效衰减、sestamibi SPECT/CT摄取增高是甲状旁腺脂肪腺瘤的影像特征。
  • 病理证实间质脂肪>50%是甲状旁腺脂肪腺瘤的诊断依据。
  • 因脂肪成分占比高,术前定位困难,多模态影像有助于准确识别。

核心结论

  • 甲状旁腺脂肪腺瘤因其影像特征而带来独特诊断挑战,认识这些特征并采用多模态影像方法是准确定位和成功手术治疗的关键。

研究设计与样本

  • 回顾性病例系列,纳入4例经病理证实且具原发性甲状旁腺功能亢进生化证据的甲状旁腺脂肪腺瘤患者,影像方法包括超声、CT和sestamibi SPECT/CT,以病理和术后生化治愈为参考。

关键影像表现/征象

  • 超声上甲状旁腺脂肪腺瘤表现为高回声。
  • CT上甲状旁腺脂肪腺瘤表现为脂肪等效衰减。
  • sestamibi SPECT/CT上甲状旁腺脂肪腺瘤表现为摄取增高。

诊断标准与关键数值

  • 病理证实间质脂肪>50%是甲状旁腺脂肪腺瘤的诊断依据。
  • 所有患者PTH升高,血钙处于正常高值至升高水平。

临床应用与阅片要点

  • 作者认为认识超声高回声、CT脂肪等效衰减和sestamibi SPECT/CT摄取增高这些特征并采用多模态影像方法,是准确定位甲状旁腺脂肪腺瘤的关键。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Parathyroid lipoadenoma (PLA) is a rare cause of primary hyperparathyroidism and is over 50% adipose tissue, which complicates preoperative localization. We aimed to describe clinical and imaging features of PLA in this case series. We retrospectively reviewed 4 patients with pathologically confirmed PLA and biochemical evidence of primary hyperparathyroidism. All patients exhibited elevated PTH and upper-normal to elevated calcium levels. PLAs demonstrated hyperechogenicity on ultrasonography, fat-equivalent attenuation on CT, and increased uptake on sestamibi SPECT/CT. Surgical excision resulted in notable intraoperative PTH decline and postoperative biochemical cure. Pathology confirmed >50% stromal fat in all cases. In conclusion, PLA presents unique diagnostic challenges because of its imaging characteristics. Awareness of these features and a multimodal imaging approach are key to accurate localization and successful surgical management.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Alizada S, Al Qudah H, Debnam JM, et al. Multimodal Imaging and Clinicopathologic Features of Parathyroid Lipoadenoma. AJNR Am J Neuroradiol. 2026. PMID: 40876948. doi:10.3174/ajnr.A8988

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。